In your work, like you said, in phase two, three, when you guys get involved, are you seeing performance metrics, AI-driven measures baked into these now? What sort of AI components do you guys focus on with your company?

Yeah, we have two sides to that.

One is in our patient screening.

So a big part of what we do is talk to patients directly, first online and then traditionally with a live nurse professional in every country where we're recruiting patients to screen those patients for their fit for the study.

So there's a scenario where I'm about to release an AI screening agent where the patient now has a choice.

Do I want to interact with a live medical professional Or maybe it's 2 a.m. in the morning and I just want to see if I qualify right now and get connected, can I keep going with an AI agent? And so we've been in development on that since earlier this year.

We're about to release that and put that into live studies.

But where maybe over the course of the next three, four years, where do you see the greatest potential and progress, hopefully from AI-aided clinical development, whether just broadly or in the recruitment area?

In your work, l- uh, like y- like you said, in phase two when you, three, when you guys get involved, are you seeing, like, performance, like metrics, measures b- uh, AI-driven measures baked into these now? What sort of AI components do you guys focus on with your company?

Yeah, we have two sides to that.

One is in our patient screening.

So a big part of what we do is talk to patients directly, first online, and then traditionally with a live nurse professional in, in every country where we're recruiting patients to screen those patients for their fit for the study.

So there's a scenario we're, um, about to release an AI screening agent where the patient now has a choice.

Do I wanna interact with a live medical professional? Or maybe it's 2:00 AM in the morning, and I just wanna see if I qualify right now and get connected.

Can I keep going with an AI agent? And so we, um, we've been in development on that since earlier this year.

But where do, where maybe in the, over the course of the next three, four years, where do you see the greatest potential, you know, and progress hopefully of, you know, from AI-aided clinical development, what, whether, you know, just broadly or, or in the recruitment area?